Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

General

General

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Biotech
  • Equities
  • General
  • Health Care
  • Large Cap
  • Media
  • News

Obesity In Children – US Parents Face Tough Time To Access Recommended Treatment, Though Novo Nordisk’s Drug Still Sees Strong Demand

By Vandana Singh
June 18, 12:30 PM
U.S. parents face significant barriers to accessing intensive behavioral counseling for childhood obesity, with programs often unavailable, not covered by insurance, and requiring substantial time commitments.

NVO

Read More
2 minute read
  • Equities
  • General
  • Management
  • Markets
  • Media
  • News
  • Top Stories

Boeing’s Search For New CEO Persists As Calhoun Faces Congressional Hearing

By Nabaparna Bhattacharya
June 18, 12:18 PM
Boeing faces escalating turbulence amid CEO search challenges and Calhoun's Capitol Hill testimony, raising uncertainty about the company's leadership direction.

BA

Read More
1 minute read
  • Biotech
  • General
  • News

XBiotech Shares Results From Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treatment For Advanced Pancreatic Cancer

By Benzinga Newsdesk
June 18, 11:48 AM
XBiotech (NASDAQ:XBIT) announced today data from its Phase 1/Phase 2 randomized, double-blind, placebo-controlled multi-center study for advanced pancreatic cancer. Known as 1-BETTER, the study examined Natrunix

XBIT

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Trading Ideas

What’s Going On With Taysha Gene Therapies Stock Tuesday?

By Vandana Singh
June 18, 11:42 AM
Taysha Gene Therapies reveals promising longer-term and initial clinical data from their REVEAL Phase 1/2 trials evaluating TSHA-102 for Rett syndrome.

TSHA

Read More
3 minute read
  • Analyst Color
  • Analyst Ratings
  • Cannabis
  • Exclusives
  • General
  • Government
  • Guidance
  • Interview
  • Management
  • Market Summary
  • Markets
  • News

Not DC, But The States: Tim Seymour Discusses How Red States Could Catalyze Cannabis Growth

By Nicolas Jose Rodriguez
June 18, 11:20 AM
Tim Seymour, portfolio manager of the $CNBS Amplify Seymour Cannabis ETF (NYSE: CNBS), is a key voice in the cannabis investment community.

CRLBF

Read More
2 minute read
  • General
  • Government
  • News
  • Regulations
  • Top Stories
  • Travel

What’s Going On With Boeing’s Shares On Tuesday

By Shivani Kumaresan
June 18, 11:17 AM
Allegations of mishandled faulty parts in Boeing's 737 Max jets have surfaced, leading to a Senate subcommittee investigation and possible new charges by the Justice Department, highlighting ongoing safety and manufacturing challenges at Boeing.

BA

Read More
1 minute read
  • General
  • Government
  • Health Care
  • Large Cap
  • News
  • Regulations
  • Top Stories

Medicare Agency To End Advance Payments Following UnitedHealth Cyberattack

By Vandana Singh
June 18, 10:52 AM
The CMS will end the advance payments program for Medicare providers and suppliers affected by the UnitedHealth Change Healthcare hack. This program, initiated in March, has disbursed over $3.27 billion. Applications close July 12.

UNH

Read More
1 minute read
  • Biotech
  • General
  • News

‘Corning Announces Collaboration With NIBRT To Help Accelerate Cell Therapy Development’

By Benzinga Newsdesk
June 18, 10:48 AM
https://www.corning.com/worldwide/en/about-us/news-events/news-releases/2024/06/corning-announces-collaboration-with-nibrt-to-help-accelerate-cell-therapy-development.htmlCorning's cutting-edge Ascent® Fixed Bed

GLW

Read More
2 minute read
  • General
  • Health Care
  • News
  • Top Stories

Amazon Expands RxPass To Medicare Members: A Closer Look At Savings

By Shivani Kumaresan
June 18, 10:44 AM
Amazon.com Inc. (NASDAQ: AMZN) enhances healthcare accessibility with its RxPass expansion to Medicare beneficiaries, promising an average savings of $70 annually per medication and aiming to reduce Medicare costs by nearly $2 billion.

AMZN

Read More
2 minute read
  • Biotech
  • Equities
  • General
  • Health Care
  • Movers
  • News
  • Trading Ideas

Intra-Cellular Therapies’ Highlights Successful Data From Second Depression Study

By Vandana Singh
June 18, 10:37 AM
Intra-Cellular Therapies reports positive topline results for Study 502 on lumateperone 42 mg as adjunctive therapy for major depressive disorder. FDA application expected in H2 2024.

ITCI

Posts pagination

Previous 1 … 5 6 7 … 2,367 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service